BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26100695)

  • 1. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis.
    Haver HL; Chua A; Ghode P; Lakshminarayana SB; Singhal A; Mathema B; Wintjens R; Bifani P
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5316-23. PubMed ID: 26100695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.
    Fujiwara M; Kawasaki M; Hariguchi N; Liu Y; Matsumoto M
    Tuberculosis (Edinb); 2018 Jan; 108():186-194. PubMed ID: 29523322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering.
    Lee BM; Harold LK; Almeida DV; Afriat-Jurnou L; Aung HL; Forde BM; Hards K; Pidot SJ; Ahmed FH; Mohamed AE; Taylor MC; West NP; Stinear TP; Greening C; Beatson SA; Nuermberger EL; Cook GM; Jackson CJ
    PLoS Pathog; 2020 Feb; 16(2):e1008287. PubMed ID: 32032366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous Mutational Patterns and Novel Mutations for Delamanid Resistance in Mycobacterium tuberculosis.
    Liu Y; Shi J; Li L; Wu T; Chu P; Pang Y; Guo Y; Gao M; Lu J
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0053122. PubMed ID: 36448833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in
    Rifat D; Li SY; Ioerger T; Shah K; Lanoix JP; Lee J; Bashiri G; Sacchettini J; Nuermberger E
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824.
    Feuerriegel S; Köser CU; Baù D; Rüsch-Gerdes S; Summers DK; Archer JA; Marti-Renom MA; Niemann S
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5718-22. PubMed ID: 21930879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme F
    Purwantini E; Loganathan U; Mukhopadhyay B
    J Bacteriol; 2018 Dec; 200(23):. PubMed ID: 30249701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice.
    Nguyen TVA; Nguyen QH; Nguyen TNT; Anthony RM; Vu DH; Alffenaar JC
    Int J Antimicrob Agents; 2023 Oct; 62(4):106953. PubMed ID: 37595848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptor.
    Somasundaram S; Anand RS; Venkatesan P; Paramasivan CN
    BMC Microbiol; 2013 Oct; 13():218. PubMed ID: 24083570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamic assisted investigation on impact of mutations in deazaflavin dependent nitroreductase against pretomanid: a computational study.
    Singh R; Shaheer M; Sobhia ME
    J Biomol Struct Dyn; 2023 Jul; 41(10):4421-4443. PubMed ID: 35574601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of transposon Tn5367 mutagenesis and a nitroimidazopyran-based selection system to demonstrate a requirement for fbiA and fbiB in coenzyme F(420) biosynthesis by Mycobacterium bovis BCG.
    Choi KP; Bair TB; Bae YM; Daniels L
    J Bacteriol; 2001 Dec; 183(24):7058-66. PubMed ID: 11717263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.
    Hartkoorn RC; Ryabova OB; Chiarelli LR; Riccardi G; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2014 May; 58(5):2944-7. PubMed ID: 24550336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients.
    Reichmuth ML; Hömke R; Zürcher K; Sander P; Avihingsanon A; Collantes J; Loiseau C; Borrell S; Reinhard M; Wilkinson RJ; Yotebieng M; Fenner L; Böttger EC; Gagneux S; Egger M; Keller PM
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid.
    Gómez-González PJ; Perdigao J; Gomes P; Puyen ZM; Santos-Lazaro D; Napier G; Hibberd ML; Viveiros M; Portugal I; Campino S; Phelan JE; Clark TG
    Sci Rep; 2021 Sep; 11(1):19431. PubMed ID: 34593898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles.
    Gurumurthy M; Mukherjee T; Dowd CS; Singh R; Niyomrattanakit P; Tay JA; Nayyar A; Lee YS; Cherian J; Boshoff HI; Dick T; Barry CE; Manjunatha UH
    FEBS J; 2012 Jan; 279(1):113-25. PubMed ID: 22023140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
    Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS
    J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.
    Schena E; Nedialkova L; Borroni E; Battaglia S; Cabibbe AM; Niemann S; Utpatel C; Merker M; Trovato A; Hofmann-Thiel S; Hoffmann H; Cirillo DM
    J Antimicrob Chemother; 2016 Jun; 71(6):1532-9. PubMed ID: 27076101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis.
    Manjunatha UH; Boshoff H; Dowd CS; Zhang L; Albert TJ; Norton JE; Daniels L; Dick T; Pang SS; Barry CE
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):431-6. PubMed ID: 16387854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delamanid Resistance: Update and Clinical Management.
    Nguyen TVA; Anthony RM; Cao TTH; Bañuls AL; Nguyen VAT; Vu DH; Nguyen NV; Alffenaar JC
    Clin Infect Dis; 2020 Dec; 71(12):3252-3259. PubMed ID: 32521000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening mutations in drug-resistant Mycobacterium tuberculosis strains in Yunnan, China.
    Li D; Song Y; Zhang CL; Li X; Xia X; Zhang AM
    J Infect Public Health; 2017; 10(5):630-636. PubMed ID: 28623123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.